Kangmei Pharma | 600518 - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Akebia Therapeutics 362.52M 357.69M 2026-03
Alaunos Therapeutics USD 1.07M 215K 2023-06
Avita Medical AUD 1.25M 100K 2025-06
Cspc Pharmaceutical CNY 6.76M 3.43M 2025-12
Dianthus Therapeutics USD 4.44M 263K 2024-09
Genomma Lab Internacional MXN 190.68M 972K 2025-12
Hypermarcas BRL 36.54M 3.75M 2025-12
Ionis Pharmaceuticals USD 17M 1000K 2026-03
IQVIA Holdings USD 192M 1000K 2026-03
Jiangsu Hengrui CNY 254.59M 253.85M 2025-09
Kangmei Pharma CNY 1.82M 150K 2025-09
Moderna USD 11.49B 36B 2026-03
Organon & Co USD 128M 3M 2025-09
Revvity USD 24.72M 1.2M 2026-03
Sh Fosun Pharma CNY 321.25M 2M 2025-09
Tectonic Therapeutic USD 246.58M 246.56M 2026-03
Viatris USD 120.1M 500K 2026-03
Wuxi Apptec CNY 103.05M 37.29M 2025-06
Xeris Pharmaceuticals USD 7.15M 115K 2025-12
Zz Pientze Pharmaceu CNY 46.05M 36.5M 2025-06